Emergent BioSolutions Inc (EBS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Emergent BioSolutions Inc (EBS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7414
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Emergent BioSolutions Inc (Emergent) is a life sciences company. It focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. The company develops specialty products targeting public health threats and emerging infectious diseases. It’s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer. It uses multiple platform technologies, including the MVAtor and Emergard for delivery of its products. Its marketed products include BioThrax (anthrax vaccine adsorbed); WinRho SDF (Rho(D) immune globulin intravenous; (RSDL) reactive skin decontamination lotion; and HepaGam B for the treatment of hepatitis B. Emergent also has a developmental pipeline of candidates targeting dengue and other influenza infections. The company distributes its products in the US and Canada through its commercial sales forces and third party distributors. Emergent is headquartered in Rockville, Maryland, the US.

Emergent BioSolutions Inc (EBS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Emergent BioSolutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Emergent BioSolutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Emergent BioSolutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Emergent BioSolutions Inc, Medical Equipment, Deal Details 11
Partnerships 11
Emergent BioSolutions Enters into Licensing Agreement with Pharma Consult 11
Debt Offering 12
Emergent BioSolutions Completes Private Placement Of Notes Due 2021 For US$250 Million 12
Acquisition 14
Emergent BioSolutions Acquires Unither Virology from United Therapeutics 14
Emergent BioSolutions Inc – Key Competitors 15
Emergent BioSolutions Inc – Key Employees 16
Emergent BioSolutions Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 19
Recent Developments 20
Strategy And Business Planning 20
Sep 24, 2018: Emergent BioSolutions expands manufacturing capability with ABEC dual purpose single-use microbial fermentation / mammalian cell culture systems 20
Jun 07, 2018: Emergent BioSolutions Announces $50 Million Expansion of Baltimore Fill/Finish Facility 21
May 10, 2017: Emergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and Manufacturing in Baltimore 22
Financial Announcements 24
Aug 02, 2018: Emergent BioSolutions reports financial results for second quarter and six months of 2018 24
May 03, 2018: Emergent BioSolutions Reports First Quarter 2018 Financial Results 27
Feb 22, 2018: Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2017 Financial Results 30
Jan 08, 2018: Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook 33
Nov 02, 2017: Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance 34
Aug 03, 2017: Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance 37
May 04, 2017: Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance 40
Feb 23, 2017: Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms 2017 Guidance and Provides 2020 Goals 42
Jan 09, 2017: Emergent BioSolutions Announces Preliminary 2016 Financial Results and Provides 2017 Financial Outlook 45
Corporate Communications 46
Mar 26, 2018: Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy 46
Oct 02, 2017: Emergent BioSolutions Announces Closing of New $200 Million Senior Secured Credit Facility 47
Other Significant Developments 48
Jul 31, 2017: Emergent BioSolutions Awarded $23 Million to Develop Novel Multi-Drug Auto-Injector for U.S. Department of Defense 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Emergent BioSolutions Inc, Medical Equipment, Key Facts, 2017 2
Emergent BioSolutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Emergent BioSolutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Emergent BioSolutions Inc, Deals By Market, 2012 to YTD 2018 9
Emergent BioSolutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Emergent BioSolutions Enters into Licensing Agreement with Pharma Consult 11
Emergent BioSolutions Completes Private Placement Of Notes Due 2021 For US$250 Million 12
Emergent BioSolutions Acquires Unither Virology from United Therapeutics 14
Emergent BioSolutions Inc, Key Competitors 15
Emergent BioSolutions Inc, Key Employees 16
Emergent BioSolutions Inc, Other Locations 17
Emergent BioSolutions Inc, Subsidiaries 17
Emergent BioSolutions Inc, Joint Venture 19

List of Figures
Emergent BioSolutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Emergent BioSolutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Emergent BioSolutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Emergent BioSolutions Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Emergent BioSolutions Inc (EBS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C-TRI Co Ltd (047920):製薬・医療:M&Aディール及び事業提携情報
    Summary C-TRI Co Ltd (C-TRI), a subsidiary of DAE HWA Pharmaceutical Co Ltd, is a pharmaceutical company that offers development of new peptide drugs. The company’s products include ethicals, over-the-counter drugs, Quasi-drugs, cosmetics, amendments, pharmaceuticals, taltirelin, desmopressin, presc …
  • NCI Building Systems, Inc. (NCS):企業の財務・戦略的SWOT分析
    NCI Building Systems, Inc. (NCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • EnergyAustralia Pty Ltd-エネルギー分野:企業M&A・提携分析
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, and wind sources. EnergyAustralia offers home …
  • Turner & Townsend Plc:企業の戦略的SWOT分析
    Turner & Townsend Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Gordon Food Service, Inc.:企業の戦略・SWOT・財務情報
    Gordon Food Service, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gordon Food Service, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nordion (Canada) Inc:企業の戦略的SWOT分析
    Nordion (Canada) Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Aeroport Anapa OAO:戦略・SWOT・企業財務分析
    Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • iCardiac Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary iCardiac Technologies Inc (iCardiac) is a provider of medical laboratory services. The company’s services portfolio include cardiac safety and respiratory services, cardiac safety assessment methodology, clinical trials, electrophysiology, drug development, regulatory services, protocol deve …
  • MTR Corporation Ltd:戦略・SWOT・企業財務分析
    MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • A. Menarini Industrie Farmaceutiche Riunite Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company that undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio is focused on a …
  • Qatar Islamic Bank
    Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report Summary Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析
    Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tata Communications Limited:企業の戦略・SWOT・財務情報
    Tata Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務情報
    Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Monsoon Accessorize Ltd:企業の戦略・SWOT・財務分析
    Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report Summary Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Diazyme Laboratories Inc:企業の製品パイプライン分析2018
    Summary Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, po …
  • Ultra Petroleum Corp (UPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ultra Petroleum Corp (Ultra) is an independent upstream company, which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops long-life natural gas reserves in the Green River Basin of Wyoming, the Pinedale and Jonah fields, and oil reserves in the U …
  • Takashimaya Company, Limited:企業の戦略・SWOT・財務分析
    Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Waste Management Inc (WM):企業の財務・戦略的SWOT分析
    Waste Management Inc (WM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆